# Singapore to add HPV9 vaccine to national schedules in 2027 > HPV9 will join Singapore’s childhood and adult immunisation schedules for eligible females from 1 January 2027. The ministry says covered HPV types are associated with about 90% of cervical cancers. - Canonical URL: https://newsverum.com/en/news/singapore-hpv9-vaccine-schedule-january-2027 - Publisher: Newsverum - Section: Health - Country: Singapore - Published: 2026-10-04T14:04:24+00:00 - Updated: 2026-10-07T05:58:40+03:00 - Event / data period: 2026-10-02 - Other editions: [Türkçe](https://newsverum.com/tr/news/singapore-hpv9-vaccine-schedule-january-2027.md), [العربية](https://newsverum.com/ar/news/singapore-hpv9-vaccine-schedule-january-2027.md), [Français](https://newsverum.com/fr/news/singapore-hpv9-vaccine-schedule-january-2027.md), [Español](https://newsverum.com/es/news/singapore-hpv9-vaccine-schedule-january-2027.md), [Deutsch](https://newsverum.com/de/news/singapore-hpv9-vaccine-schedule-january-2027.md), [Português](https://newsverum.com/pt/news/singapore-hpv9-vaccine-schedule-january-2027.md) Singapore’s Ministry of Health announced on 2 October that the nine-valent HPV vaccine, HPV9, will be added to the National Childhood Immunisation Schedule, National Adult Immunisation Schedule and Subsidised Vaccine List from 1 January 2027. The change covers eligible Singaporean and permanent-resident females aged 9–26; HPV2 will remain as an alternative. The ministry says HPV16 and HPV18 are associated with about 70% of cervical cancers, while additional types covered by HPV9 account for a further 20%, bringing the combined type coverage to about 90%. The announcement recommends two doses for unvaccinated females who start at ages 9–14 and three doses for those who start at ages 15–26; an incomplete course may be finished after age 26 and up to age 45. Some secondary-school students who began with HPV2 in 2026 will receive HPV9 as their second dose in 2027. Type coverage is not a measure of vaccine efficacy or an individual’s probability of protection; additional HPV9 doses are not recommended for people who have completed a recommended course. ## Data ### Singapore’s HPV9 schedule and HPV-type coverage Programme rules announced by the Ministry of Health on 2 October 2026 for 1 January 2027, plus the shares of cervical cancers associated with HPV types covered by the vaccines. Methodology: The release’s 70% and further 20% figures are source estimates of the shares of cervical cancers associated with HPV types; they are not clinical vaccine efficacy or individual protection rates. The approximately 90% total describes the type coverage stated by the source. Dose counts are programme recommendations for unvaccinated females starting at the stated ages; prior vaccination and individual clinical circumstances require medical advice. | label | value | unit | period | basis | |---|---|---|---|---| | Recommended doses for those starting HPV vaccination at ages 9–14 | 2 | doses | 2027-01-01 | target | | Recommended doses for those starting HPV vaccination at ages 15–26 | 3 | doses | 2027-01-01 | target | Sources: · Download data: [JSON](https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027/data/hpv9-schedule-and-type-coverage?lang=en&format=json) · [CSV](https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027/data/hpv9-schedule-and-type-coverage?lang=en&format=csv) ## Sources - [Ministry of Health, Singapore]() (Source checked: 2026-10-04; Published: 2026-10-02) ## Correction history - 2026-10-07T00:55:21+03:00: German and Portuguese editions and translations of the data and correction explanations have been added to this article. - 2026-10-07T05:58:40+03:00: Data classification corrected: measure identifiers and types now follow the dataset rules. No figure, unit or date changed. --- Cite the canonical URL above. [Editorial standards and corrections](https://newsverum.com/en/editorial)